Speeding Up Generic Drug Access by Correcting Misleading Patent Information.
This law aims to accelerate the availability of cheaper generic medications. It grants generic drug manufacturers the right to sue brand-name companies to correct or remove inaccurate patent information (use codes) that might unfairly delay generic drug approval. This change is intended to lower prescription drug costs for consumers.
Key points
Generic drug makers gain a new legal tool to challenge misleading patent listings related to specific drug usage methods.
The goal is to speed up the market entry of affordable generic alternatives, potentially reducing out-of-pocket expenses for patients.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.